Clinical Trial

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2020-08-30; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2021-01-12
Trial Details
NCT Number NCT04534127
Lead Sponsor Alpha Tau Medical LTD.
Conditions Skin Cancer, Mucosal Neoplasm of Oral Cavity, Soft Tissue Neoplasm
Enrollment 56 participants
Start Date 2020-12-22
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-16